article thumbnail

Monthly Round-Up of What to Read on Pharma Law and Policy

Bill Of Health

Transparency practices at the FDA: A barrier to global health. Implications of Oncology Trial Design and Uncertainties in Efficacy-Safety Data on Health Technology Assessments. 2022 Aug 5;377(6606):572-574. Epub ahead of print. Curr Oncol. 2022 Aug 16;29(8):5774-5791.

article thumbnail

Newsletter, February 2024

Patient Safety Movement

This brings up the concept of wearable digital health technologies for monitoring. In fact, in a 2023 Gallup Poll, it was reported that 38% of families 4 in the United States chose to skip recommended medical care or the purchase of needed pharmaceuticals due to cost and budgetary pressures within the home.